133,548 research outputs found
Drug Evaluation: Adi-Peg-20 - a Pegylated Arginine Deiminase for Arginine -Auxotrophic Cancers
No full textPheonix is developing ADI-PEG-20, a PEGylated arginine deiminase for the potential treatment of hepatocellular carcinoma, for which the Food and Drug Administration (FDA) and the European Agency for the Evaluation of Medicinal Products have granted the drug Orphan Drug status, and melanoma, for which the FDA has also awarded ADI-PEG-20 Orphan Drug status. ADI-PEG -20 is also being investigated for the potential treatment of influenza virus infection and hepatitis C virus infection
Face recognition using linear representation ensembles
No full textAbstract not availableHanxi Li, Fumin Shen, Chunhua Shen, Yang Yang, Yongsheng Ga
Dataset for Fiber Integrated Wavelength Converter Based on a Silicon Core Fiber with a Nano-spike Coupler
No full textThis dataset provides the data for the figures in the following paper: Meng Huang, Ren, Haonan, Shen, Li and Peacock, Anna (2019) Fiber Integrated Wavelength Converter Based on a Silicon Core Fiber with a Nano-spike Coupler. IEEE Photonics Technology Letters</span
Dataset for Low-loss silicon core fibre platform for mid-infrared nonlinear photonics
No full textThis dataset provides the data for the figures in the following paper: Ren, Haonan, Shen, Li, Runge, Antoine F. J., Hawkins, Thomas W., Ballato, John, Gibson, Ursula and Peacock, Anna (2019) Low-loss silicon core fibre platform for mid-infrared nonlinear photonics. Light: Science & Applications</span
Dataset for Nonlinear optical properties of polycrystalline silicon core fibers from telecom wavelengths into the mid-infrared spectral region
No full textThis dataset provides the data for the figures in the following paper: Ren, Haonan, Shen, Li and Peacock, Anna (2018) Nonlinear optical properties of polycrystalline silicon core fibers from telecom wavelengths into the mid-infrared spectral region. Optical Materials Express</span
Parabolopona quadrispinosa Shang, Zhang, Shen & Li 2006
No full textParabolopona quadrispinosa Shang, Zhang, Shen & Li, 2006 Parabolopona quadrispinosa Shang, Zhang, Shen & Li, 2006: 37, Figs 16–21. Distribution: China (Guangxi, Yunnan).Published as part of Qu, Ling, Webb, M. D. & Dai, Ren-Huai, 2015, A new genus and species of the leafhopper subtribe Paraboloponina from China (Hemiptera, Cicadellidae), pp. 260-270 in Zootaxa 3919 (2) on page 265, DOI: 10.11646/zootaxa.3919.2.2, http://zenodo.org/record/24119
Sichuana Shen & Yin 2020
No full textGenus Sichuana Shen & Yin, 2020 Type species: Sichuana cryptospina Shen & Yin, 2020 Include species: type species and the new species described herePublished as part of He, Zhu-Qing, Gong, Pu, Hu, Tian-Hao, Yin, Zi-Xu, Shen, Zi-Hao, Wang, Bai-Qiu & Li, Kai, 2020, A new species of genus Sichuana from Sichuan, China (Orthoptera: Tettigoniidae Tettigoniinae), pp. 195-200 in Zootaxa 4877 (1) on pages 195-196, DOI: 10.11646/zootaxa.4877.1.10, http://zenodo.org/record/442371
Analysis of the reimbursements of pharmaceutical services in health insurance contracted pharmacies in Taiwan and Japan
No full text奈米醫學在腎臟移植排斥的應用-Sirolimus
No full textNanomedicine, known as the application of nanotechnology in medicine, has been applied to overcome the problems of poor bioavailability, in vitro and in vivo stability, and targeted delivery in the preparation of pharmaceutical products. Sirolimus, a water-insoluble immunosuppressant, has been formulated into an oral solid dosage form by using NanoCrystal((R )) technology to increase the water solubility and thereby the bioavailability. The efficacy, safety, and pharmacokinetic properties are not significantly different between liquid and solid formulations except that less fluctuation of sirolimus blood concentration was observed in solid dosage form. The tablet formulation offers the advantages of better palatability and more convenience for long-tern use. Sirolimus tablets are not only a successful example of nanomedicine, but also a more cost- effective treatment in renal transplantation than cyclosporine and tacrolimus
- …
